Liver Spheroid Model for NASH Phenotype Reproduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro models of nonalcoholic steatohepatitis (NASH) fail to accurately mimic the physiological behavior of the liver during the disease, making it challenging to develop effective therapies due to the complexity of the disease and the lack of a reliable experimental model.
Innovation Solution
A method for preparing a liver spheroid by seeding and culturing human hepatocytes, stellate cells, liver endothelial cells, and Kupffer cells in a controlled ratio, under specific conditions to induce a NASH-like phenotype, which mimics the progression from steatosis to fibrosing NASH.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If immortalized human cell lines (Huh7, HepG2) or iPSC-derived hepatocytes are used to induce steatotic phenotype, then the cells can be cultured in vitro, but they barely reflect the native liver metabolic function
Solution Approach 1:
The liver is segmented into its four main cell types (hepatocytes, stellate cells, endothelial cells, and Kupffer cells), with each cell type being cultured separately first and then combined in a co-culture system. This segmentation allows each cell type to maintain its specific physiological characteristics while collectively reproducing the complex liver metabolic function and NASH phenotype.
Solution Approach 2:
The invention creates a composite in vitro liver model by combining four different human hepatic cell types in specific ratios within a 3D spheroid structure. This composite approach integrates the metabolic functions of hepatocytes with the supportive and regulatory functions of stellate cells, endothelial cells, and Kupffer cells, thereby achieving both high reliability in reflecting native liver function and adaptability in reproducing NASH disease phenotype.
2Reliability
If cocultures approach is used with multiple hepatic cell types, then more liver functions can be represented, but the lack of control of cellular ratio and poor differentiation do not fully recapitulate the NASH phenotype
Solution Approach 1:
The invention optimizes and controls critical parameters including the ratios of the four hepatic cell types (hepatocytes:stellate cells:endothelial cells:Kupffer cells = 60-80%:10-30%:3-10%:3-10%), the 3D spheroid structure configuration, and culture conditions. By precisely controlling these parameters, the model achieves both high manufacturing precision in cellular composition and high reliability in NASH phenotype recapitulation.
3Reliability
If in vivo conditions are translated into in vitro setups, then physiological behavior can be mimicked, but the complexity of the disease makes identification of new therapies challenging
Solution Approach 1:
The invention transitions from traditional 2D monolayer cultures to 3D spheroid structures, adding a spatial dimension that better mimics the physiological architecture of liver tissue. This dimensional change enables more accurate representation of cell-cell interactions, nutrient diffusion gradients, and metabolic functions while maintaining a manageable model complexity for therapeutic screening.
Data Source
AI summary
The present invention relates to methods for preparing in vitro models of nonalcoholic steatohepatitis.